You are here

Incivo

Vertex Gains on Sale of Drug Rights to Johnson & Johnson Unit

Barron's

Wed, 11/20/13 - 04:37 pm

Vertex Pharmaceuticals

Two Hepatitis C Treatments Win U.K. Health-Cost Agency Backing

Bloomberg

Wed, 04/25/12 - 10:17 am

German Review Panel Sees Added Benefit for J&J Hepatitis C Drug

Bloomberg

Mon, 01/16/12 - 05:18 pm

Street Still Underestimating J&J’s Pipeline: Citi

Barron's

Thu, 08/4/11 - 09:17 am

J&J Wins European Panel’s Backing of Cancer, Hepatitis Drugs

Bloomberg

Sat, 07/23/11 - 04:32 pm

prostate cancer